Pelage Pharmaceuticals
Latest round
- Series B
Last raised
- Sep 2025
Total raised
- $151M
Investors
- 5
About Pelage Pharmaceuticals
Based in California, US, and founded in 2018 by co-founders William Lowry, heather Christofk, Michel Jung, Pelage Pharmaceuticals, Inc. operates as a medicine-based company providing treatments for hair loss including androgenetic alopecia and chemotherapy-induced-alopecia. In October 2025, Pelage Pharmaceuticals, Inc. Pelage Pharmaceuticals, Inc. developed a medicines-based platform to target the unique metabolic switch of hair follicle stem cells. The company’s mechanism, which is activated by a small molecule drug platform, stimulates robust hair growth without invasive procedures or systemic exposure. In addition, the firm’s treatment focus on androgenetic alopecia, chemotherapy, scarring alopecia, telogen effluvium, and alopecia areata to create hair, with a focus on molecular and stem cell biology.
Who invested in Pelage Pharmaceuticals
5 investors across 3 rounds
See all investors in Pelage Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Pelage Pharmaceuticals
Who invested in Pelage Pharmaceuticals?
Pelage Pharmaceuticals has 5 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Pelage Pharmaceuticals raised?
Pelage Pharmaceuticals has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Pelage Pharmaceuticals last raise money?
Pelage Pharmaceuticals's most recent round on record is a Series B, in Sep 2025.
What does Pelage Pharmaceuticals do?
Based in California, US, and founded in 2018 by co-founders William Lowry, heather Christofk, Michel Jung, Pelage Pharmaceuticals, Inc.
Where is Pelage Pharmaceuticals headquartered?
Pelage Pharmaceuticals is headquartered in Los Angeles, US.
Which VCs invest in companies like Pelage Pharmaceuticals?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Pelage Pharmaceuticals's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Pelage Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.